Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 340

1.

The transformation of the nuclear nanoarchitecture in human field carcinogenesis.

Bauer GM, Stypula-Cyrus Y, Subramanian H, Cherkezyan L, Viswanathan P, Zhang D, Iyengar R, Bagalkar S, Derbas J, Graff T, Gladstein S, Almassalha LM, Chandler JE, Roy HK, Backman V.

Future Sci OA. 2017 May 5;3(3):FSO206. doi: 10.4155/fsoa-2017-0027. eCollection 2017 Aug. Review.

2.

Transabdominal Breast Augmentation: A Review of 114 Cases Performed over 14 Years.

Bhatt RA, Iyengar RJ, Karacaoglu E, Zienowicz RJ.

Plast Reconstr Surg. 2017 Sep;140(3):476-487. doi: 10.1097/PRS.0000000000003611.

PMID:
28841606
3.

Effect of patient-reported smoking status on short-term bariatric surgery outcomes.

Inadomi M, Iyengar R, Fischer I, Chen X, Flagler E, Ghaferi AA.

Surg Endosc. 2017 Jul 20. doi: 10.1007/s00464-017-5728-1. [Epub ahead of print]

PMID:
28730276
4.

Diagnosis and Management of Dermatofibrosarcoma Protuberans in a 3-Year-Old Patient.

Iyengar R, Kiwanuka E, Mangray S, Cruz AP, Katarincic J, Bhatt R.

J Hand Surg Am. 2017 Sep;42(9):756.e1-756.e5. doi: 10.1016/j.jhsa.2017.04.009. Epub 2017 May 24.

PMID:
28549894
5.

Fragility of foot process morphology in kidney podocytes arises from chaotic spatial propagation of cytoskeletal instability.

Falkenberg CV, Azeloglu EU, Stothers M, Deerinck TJ, Chen Y, He JC, Ellisman MH, Hone JC, Iyengar R, Loew LM.

PLoS Comput Biol. 2017 Mar 16;13(3):e1005433. doi: 10.1371/journal.pcbi.1005433. eCollection 2017 Mar.

6.

A biomimetic gelatin-based platform elicits a pro-differentiation effect on podocytes through mechanotransduction.

Hu M, Azeloglu EU, Ron A, Tran-Ba KH, Calizo RC, Tavassoly I, Bhattacharya S, Jayaraman G, Chen Y, Rabinovich V, Iyengar R, Hone JC, He JC, Kaufman LJ.

Sci Rep. 2017 Mar 6;7:43934. doi: 10.1038/srep43934.

7.

The Reply.

Ciesielski T, Iyengar R, Bothra A, Tomala D, Cislo G, Gage BF.

Am J Med. 2017 Mar;130(3):e115. doi: 10.1016/j.amjmed.2016.10.029. Epub 2017 Jan 30. No abstract available.

PMID:
28153335
8.

Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells.

Stillitano F, Hansen J, Kong CW, Karakikes I, Funck-Brentano C, Geng L, Scott S, Reynier S, Wu M, Valogne Y, Desseaux C, Salem JE, Jeziorowska D, Zahr N, Li R, Iyengar R, Hajjar RJ, Hulot JS.

Elife. 2017 Jan 30;6. pii: e19406. doi: 10.7554/eLife.19406.

9.

Risk, Benefit, and Cost Thresholds for Emergency Department Testing: A Cross-sectional, Scenario-based Study.

Meka AP, Porath JD, Iyengar R, Morrow C, Fagerlin A, Meurer WJ.

Acad Emerg Med. 2017 Jun;24(6):686-690. doi: 10.1111/acem.13148. Epub 2017 Mar 17.

PMID:
27987314
10.

Procedures for risk-stratification of lung cancer using buccal nanocytology.

Subramanian H, Viswanathan P, Cherkezyan L, Iyengar R, Rozhok S, Verleye M, Derbas J, Czarnecki J, Roy HK, Backman V.

Biomed Opt Express. 2016 Aug 31;7(9):3795-3810. eCollection 2016 Sep 1.

11.

The prevalence of metabolic syndrome among law enforcement officers who responded to the 9/11 World Trade Center attacks.

Moline JM, McLaughlin MA, Sawit ST, Maceda C, Croft LB, Goldman ME, Garcia MJ, Iyengar RL, Woodward M.

Am J Ind Med. 2016 Sep;59(9):752-60. doi: 10.1002/ajim.22649.

PMID:
27582477
12.

Management of Craniosynostosis at an Advanced Age: Controversies, Clinical Findings, and Surgical Treatment.

Iyengar RJ, Klinge PM, Chen WS, Boxerman JL, Sullivan SR, Taylor HO.

J Craniofac Surg. 2016 Jul;27(5):e435-41. doi: 10.1097/SCS.0000000000002725.

PMID:
27380569
13.

The Noncanonical Role of ULK/ATG1 in ER-to-Golgi Trafficking Is Essential for Cellular Homeostasis.

Joo JH, Wang B, Frankel E, Ge L, Xu L, Iyengar R, Li-Harms X, Wright C, Shaw TI, Lindsten T, Green DR, Peng J, Hendershot LM, Kilic F, Sze JY, Audhya A, Kundu M.

Mol Cell. 2016 Jun 16;62(6):982. doi: 10.1016/j.molcel.2016.05.030. Epub 2016 Jun 16. No abstract available.

14.

The Noncanonical Role of ULK/ATG1 in ER-to-Golgi Trafficking Is Essential for Cellular Homeostasis.

Joo JH, Wang B, Frankel E, Ge L, Xu L, Iyengar R, Li-Harms X, Wright C, Shaw TI, Lindsten T, Green DR, Peng J, Hendershot LM, Kilic F, Sze JY, Audhya A, Kundu M.

Mol Cell. 2016 May 19;62(4):491-506. doi: 10.1016/j.molcel.2016.04.020.

15.

Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel.

Iyengar RN, LeFrancois AL, Henderson RR, Rabbitt RM.

J Manag Care Spec Pharm. 2016 May;22(5):550-60. doi: 10.18553/jmcp.2016.22.5.550.

16.

Worsening of Callus Hyperplasia after Bisphosphonate Treatment in Type V Osteogenesis Imperfecta.

Ranganath P, Stephen J, Iyengar R, Phadke SR.

Indian Pediatr. 2016 Mar;53(3):250-2.

17.

Utilization and Costs of Compounded Medications for Commercially Insured Patients, 2012-2013.

McPherson T, Fontane P, Iyengar R, Henderson R.

J Manag Care Spec Pharm. 2016 Feb;22(2):172-81. doi: 10.18553/jmcp.2016.22.2.172.

18.

Elevated Skull Fractures: an Under-Recognized Entity.

Gupta R, Iyengar R, Kayal A, Songara A.

Indian J Surg. 2015 Dec;77(Suppl 3):1308-12. doi: 10.1007/s12262-014-1093-7. Epub 2014 May 17. Review.

19.

A Tool to Assess Risk of De Novo Opioid Abuse or Dependence.

Ciesielski T, Iyengar R, Bothra A, Tomala D, Cislo G, Gage BF.

Am J Med. 2016 Jul;129(7):699-705.e4. doi: 10.1016/j.amjmed.2016.02.014. Epub 2016 Mar 9.

20.

MEDICINE. Personalization in practice.

Iyengar R, Altman RB, Troyanskya O, FitzGerald GA.

Science. 2015 Oct 16;350(6258):282-3. doi: 10.1126/science.aad5204. No abstract available.

PMID:
26472898

Supplemental Content

Loading ...
Support Center